集泰股份(002909.SZ)上半年淨利預增43.83%-91.77%
格隆匯 7 月 5日丨集泰股份(002909.SZ)公佈,預計2020年上半年實現歸屬於上市公司股東的淨利潤4500萬元–6000萬元,同比增長43.83%-91.77%。
公告稱,受新型冠狀病毒肺炎疫情影響,公司2020年第一季度經營業績出現一定程度下降。第二季度隨着國內疫情得到有效控制,下游建築工程建設回暖帶動公司建築密封膠需求和訂單量的迅速回升,公司緊抓行業發展機遇,提升市場佔有份額;此外,受益於塗料行業環保監管趨嚴的發展趨勢,公司水性塗料產品在鋼結構和石化裝備等工業防腐領域保持較快的增長,對公司2020年上半年整體業績產生積極影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.